Onderneming Sensei Biotherapeutics, Inc.
Aandelen
SNSE
US81728A1088
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,9917 USD | -1,81% | -0,83% | +43,31% |
Vakgebied
Aantal werknemers: 28
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 01-02-18 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 01-07-20 |
Chief Tech/Sci/R&D Officer | 51 | 01-09-19 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-18 |
Michael Biega
IRC | Investor Relations Contact | - | 01-06-22 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | 01/11 |
General Counsel | - | 01-07-22 | |
Bao Le
LAW | General Counsel | - | 01-06-21 |
Corporate Officer/Principal | 44 | 01-06-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 08-03-22 |
John Celebi
CEO | Chief Executive Officer | 52 | 01-02-18 |
Bob Holmen
BRD | Director/Board Member | 60 | 01-01-17 |
Thomas Ricks
BRD | Director/Board Member | 70 | 01-01-15 |
Deneen Vojta
BRD | Director/Board Member | 59 | 29-01-20 |
James Peyer
BRD | Director/Board Member | 37 | 01-01-20 |
Kristian Humer
BRD | Director/Board Member | 49 | 30-07-21 |
Jessie English
BRD | Director/Board Member | 60 | 01-04-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 070 980 | 16 384 834 ( 65,35 %) | 0 | 65,35 % |
Bedrijfsgegevens
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,31% | 24,86 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,08% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-8,63% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |
- Beurs
- Aandelen
- Koers SNSE
- Onderneming Sensei Biotherapeutics, Inc.